Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Clinical trials continue to support the utility of Merck's new coxib MK-0663

July 26, 2000

Chiron halts clinical development of rhIGF-I in osteoarthritis

July 25, 2000

Major European market launches for Enbrel

July 21, 2000

Takeda patents thiazolidine MMP inhibitors

July 19, 2000

Ciblex's CBX-21404 shows biological activity in mice

July 18, 2000

Methods of treating or preventing arthritic conditions with MEK inhibitors

July 14, 2000

Integrin-inhibitory compounds designed by Celltech for inflammatory and immune conditions

July 14, 2000

Nonsteroidal antiinflammatory agents with reduced metabolic effects presented by Schering

July 14, 2000

Serono licenses TNF antibody patents to Knoll and Centocor

July 14, 2000

Centaur's new antiinflammatory agents reportedly act by inhibiting COX-2 induction

July 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...